Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with graves' disease (GD) and idiopathic myxoedema

Clinical and Experimental Immunology

Volumn 110, Issue 3, 1997, Pages 434-439

  Kawakami, A ^a   Eguchi, K ^a   Matsuoka, N ^a   Tsuboi, M ^a   Urayama, S ^a   Kawabe, Y ^a   Tamara, K ^b   Ishikawa, N ^c   Ito, K ^c   Nagataki, S ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c ITO HOSPITAL   (Japan)

Author keywords

Bcl 2; Fas mediated apoptosis; Thyrocytes; Thyroid stimulation blocking antibodies; Thyroid stimulating antibodies

Indexed keywords

FAS ANTIGEN; IMMUNOGLOBULIN G; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROTROPIN RECEPTOR;

APOPTOSIS; ARTICLE; GRAVES DISEASE; HUMAN; HUMAN CELL; MYXEDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CELL;

EID: 9844244551     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4301447.x     Document Type: Article

References (32)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-57.
2. Rittmaster RS, Magor KE, Manning AP et al. Differential effect of 5α-reductase inhibition and castration on androgen-regulated gene expression in rat prostate. Mol Endocrinol 1991; 5:1023-9.
3. Kyprianou N, Issacs JT. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 1988; 122:552-62.
4. Dremier S, Golstein J, Mosselmans R et al. Apoptosis in dog thyroid cells. Biochem Biophys Res Commun 1994; 200:52-58.
5. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic control on cell death. Cell 1993; 74:777-9.
6. Itoh N, Yonehara S, Ishii A et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66:233-43.
7. Kawakamim A, Eguchi K, Matsuoka N et al. Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. Endocrinology 1996; 137:3163-9.
8. Fenzi GF, Vitti P, Marcocci C et al. TSH receptor autoantibodies affecting thyroid function. In: Pinchera A, Ingber SH, Mckenzie JM, Fenzi GF, eds. Thyroid autoimmunity. New York: Plenum Press, 1987:83-90.
9. Mckenzi JM. LATS/TSAb: then and now. In: Pinchera A, Ingbar SH, Mckenzie JM, Fenzi GF, eds. Thyroid Autoimmunity. New York: Plenum Press, 1987:63-68.
10. Mitani Y, Shigemasa C, Taniguchi S et al. Studies on anti-TSH receptor antibodies in autoimmune thyroid disease. In: Lee M, Koh C-S, Eastman CJ, Nagataki S, eds. Progress in thyroidology. Seoul: Korea Medical Publishing Co, 1989:143-6.
11. Kohn LD, Alvarez F, Marcocci C et al. Monoclonal antibody studies defining the origin and properties of autoantibodies in Graves' disease. Ann NY Acad Sci 1986; 475:157-73.
12. Yoshida T, Ichikawa Y, Ito K et al. Monoclonal antibodies to the thyrotropin receptor bind to a 56-kDa subunit of the thyrotropin receptor and show heterogenous bioactivities. J Biol Chem 1988; 263:16341-7.
13. Baker JR Jr, Saunders NB, Kaulfesrch W et al. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen. J Immunol 1988; 140:2593-9.
14. Hill BL, Erlanger BF. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients. Endocrinology 1988; 122:2840-50.
15. Sato K, Yamazaki K, Shizume K et al. Stimulation by thyroid-stimulating hormone and Graves' immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and mRNA expression in the rat thyroid in vivo. J Clin Invest 1995; 96:1295-302.
16. McKenzie JM, Zakarija M. Antibodies in autoimmune thyroid disease. In: Braverman LE, Utiger RD, eds. The thyroid. Philadelphia: J.B. Lippincott Co., 1991:506-24.
17. Matsunaga M, Eguchi K, Fukuda T et al. Class II major histocompatibility complex antigen expression and cellular interaction in thyroid glands of Graves' disease. J Clin Endocrinol Metab 1986; 62:723-38.
18. Kawakami A, Eguchi K, Matsuoka N et al. Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor β1. Arthritis Rheum 1996; 39:1267-76.
19. Nicoletti I, Migliorati G, Pagliacci MC et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139:271-9.
20. Berchem GJ, Bosseler M, Venci LA et al. Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells. Cancer Res 1995; 55:735-8.
21. Rittmaster RS, Manning AP, Wright AS et al. Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5α-reductase inhibitor finasteride. Endocrinology 1995; 136:741-8.
22. Taminoto C, Hirakawa H, Kawasaki H et al. Apoptosis in thyroid diseases; a histological study. Endocr J 1995; 42:193-201.
23. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993; 151:621-7.
24. Weller M, Frei K, Groscurth P et al. Anti-Fas/Apo-1 antibody-mediated apoptosis of cultured human glioma cells: induction and modulation of sensitivity by cytokines. J Clin Invest 1994; 94:954-64.
25. Owen-Schaub LB, Radinsky R, Kruzel E et al. Anti-Fas on nonhematopoietic tumors: level of Fas/Apo-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res 1994; 54:1580-6.
26. Colombel M, Symmans F, Gil S et al. Detection of the apoptosis-suppressing oncoprotein Bcl-2 in hormone-refractory human prostate cancers. Am J Pathol 1993; 143:390-400.
27. Ishikawa N, Eguchi K, Otsubo T et al. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease. J Clin Endocrinol Metab 1987; 65:17-23.
28. Margolick JB, Weetman AP, Burman KD. Immunohistochemical analysis of intrathyroidal lymphocytes in Graves' disease: evidence of activated T cells and production of interferon-γ. Clin Immunol Immunophathol 1988; 47:208-18.
29. Ishikawa N, Eguchi K, Ueki Y et al. Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease. Clin Exp Immunol 1993; 94:363-70.
30. Alderson MR, Tough TW, Davis-Smith T et al. Fas ligand mediate activation-induced cell death in human T lymphocytes. J Exp Med 1995; 181:71-77.
31. Suda T, Okazaki T, Naito Y et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995; 154:3806-13.
32. Volpe R. Autoimmune thyroiditis. In: Braverman LE, Utiger RD, eds. The thyroid. Philadelphia: J.B. Lippincott Co., 1991:921-33.